Similar Search Results

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia : a Markov model parameterized using administrative data

Frey, Simon; Linder, Roland; Juckel, Georg; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 15 (2014) 2, pp. 133-142

Persistent link: https://www.econbiz.de/10010254965

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data

Frey, Simon; Linder, Roland; Juckel, Georg; Stargardt, Tom - In: The European Journal of Health Economics 15 (2014) 2, pp. 133-142

We use longitudinal patient-level data from a German sickness fund with 7.26 million insured in a Markov-simulation model to assess the cost-effectiveness of long-acting injectable risperidone (LAI-RIS) compared with long-acting injectable flupentixol (LAI-FLX) in the long-term management of...

Persistent link: https://www.econbiz.de/10010993904